Your browser doesn't support javascript.
loading
Oncologist approaches to communicating uncertain disease status in pediatric cancer: a qualitative study.
Porter, Amy S; Woods, Cameka; Stall, Melanie; Velrajan, Srilakshmi; Baker, Justin N; Mack, Jennifer W; Kaye, Erica C.
Affiliation
  • Porter AS; St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Woods C; St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Stall M; The University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Velrajan S; The University of Memphis, Memphis, TN, USA.
  • Baker JN; St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Mack JW; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Kaye EC; Boston Children's Hospital, Boston, MA, USA.
BMC Cancer ; 22(1): 1109, 2022 Oct 31.
Article in En | MEDLINE | ID: mdl-36316675
BACKGROUND: Most patients with cancer and their caregivers desire honest, clear prognostic communication, yet oncologists often disclose prognosis inconsistently. Prognostic communication becomes even more challenging when disease progression is unclear or equivocal. Presently, oncologist approaches for discussing uncertain disease findings are poorly understood. METHODS: In this prospective, longitudinal study, we audio-recorded serial disease reevaluation conversations between children with high-risk cancer, their families, and their primary oncologists over 24 months and conducted content analysis at recorded timepoints when oncologists categorized disease progression as equivocal. RESULTS: Of the 265 medical discussions recorded across the illness course for 33 patient-parent dyads, a total of 40 recorded discussions took place at equivocal timepoints, comprising > 500 min of medical dialogue. Prognosis talk encompassed < 3% of dialogue and was absent in nearly half of equivocal discussions (17/40, 42.5%). Curability statements were identified in only two conversations. Inductive content analysis of dialogue revealed four distinct patterns for communicating equivocal disease status: (1) up-front reassurance, (2) softening the message, (3) describing possible disease progression without interpretation, (4) expressing uncertainty without discussing the bigger picture. CONCLUSION: Oncologists rarely discuss prognosis with children with high-risk cancer and their families at timepoints when disease progression is not definitive. Formal guidance is needed to better support oncologists in navigating uncertainty while sharing honest, person- and family-centered information about prognosis.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Physician-Patient Relations / Truth Disclosure / Oncologists / Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Child / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Physician-Patient Relations / Truth Disclosure / Oncologists / Neoplasms Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Child / Humans Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States